These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11972432)

  • 1. Antenatal glucocorticoids and the developing brain: mechanisms of action.
    Matthews SG
    Semin Neonatol; 2001 Aug; 6(4):309-17. PubMed ID: 11972432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal glucocorticoids and renal function after birth.
    Jahnukainen T; Chen M; Berg U; Celsi G
    Semin Neonatol; 2001 Aug; 6(4):351-5. PubMed ID: 11972436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids, inflammation and the perinatal lung.
    Jobe AH
    Semin Neonatol; 2001 Aug; 6(4):331-42. PubMed ID: 11972434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of antenatal glucocorticoids according to the cause of very premature birth.
    Foix-L'helias L; Baud O; Lenclen R; Kaminski M; Lacaze-Masmonteil T
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F46-8. PubMed ID: 15613573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal steroid therapy: have we undervalued the risks?
    Cavalieri RL; Cohen WR
    J Matern Fetal Neonatal Med; 2006 May; 19(5):265-9. PubMed ID: 16753765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal betamethasone: reassuring long-term data.
    Prescrire Int; 2008 Apr; 17(94):73. PubMed ID: 18536142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids.
    Kapoor A; Petropoulos S; Matthews SG
    Brain Res Rev; 2008 Mar; 57(2):586-95. PubMed ID: 17716742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal therapies and the developing brain.
    Adams DF; Ment LR; Vohr B
    Semin Neonatol; 2001 Apr; 6(2):173-83. PubMed ID: 11483022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Administration of glucocorticosteroids to premature infants: increasing evidence of adverse effects].
    van Bel F
    Ned Tijdschr Geneeskd; 2001 Dec; 145(52):2521-5. PubMed ID: 11793826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences.
    O'Regan D; Welberg LL; Holmes MC; Seckl JR
    Semin Neonatol; 2001 Aug; 6(4):319-29. PubMed ID: 11972433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Repeat doses of prenatal corticosteroids for women at risk of preterm birth: a difficult consensus].
    Guilherme R; Renaud C; Dommergues M; Mitanchez D
    J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):459-68. PubMed ID: 19473782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hormones on fetal lung development.
    Bizzarro MJ; Gross I
    Obstet Gynecol Clin North Am; 2004 Dec; 31(4):949-61, xii. PubMed ID: 15550344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation.
    Finken MJ; Keijzer-Veen MG; Dekker FW; Frölich M; Walther FJ; Romijn JA; van der Heijden BJ; Wit JM;
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F442-7. PubMed ID: 18450806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal glucocorticoids and growth: single versus multiple doses in animal and human studies.
    Newnham JP; Moss TJ
    Semin Neonatol; 2001 Aug; 6(4):285-92. PubMed ID: 11972430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antepartum glucocorticoid therapy suppresses human placental xenobiotic and steroid metabolizing enzymes.
    Paakki P; Kirkinen P; Helin H; Pelkonen O; Raunio H; Pasanen M
    Placenta; 2000; 21(2-3):241-6. PubMed ID: 10736248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple courses of antenatal glucocorticoid treatment and fetal outcome.
    Lacaze-Masmonteil T; Audibert F
    J Perinat Med; 2000; 28(3):185-93. PubMed ID: 10923302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of prenatal glucocorticoid treatment in the preterm infant.
    Rubaltelli FF; Chiti G; Dani C
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():35-8. PubMed ID: 10021715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
    Ring AM; Garland JS; Stafeil BR; Carr MH; Peckman GS; Pircon RA
    Am J Obstet Gynecol; 2007 May; 196(5):457.e1-6. PubMed ID: 17466700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of glucocorticoid therapy in preventing early neonatal complications in preterm delivery.
    Madarek EO; Najati N
    J Perinat Med; 2003; 31(5):441-3. PubMed ID: 14601269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of glucocorticoid receptor regulation in the rat forebrain: implications for adverse effects of glucocorticoids in preterm infants.
    Slotkin TA; Seidler FJ; Wood CR; Lau C
    Brain Res Bull; 2008 Jul; 76(5):531-5. PubMed ID: 18534262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.